|
Collaborative Study of 1,3 Butadiene Biomarkers Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Collaborative Study of 1,3 Butadiene Biomarkers conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Collaborative Study of 1,3 Butadiene Biomarkers Clinical research trials and Collaborative Study of 1,3 Butadiene Biomarkers medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Collaborative Study of 1,3 Butadiene Biomarkers. Collaborative Study of 1,3 Butadiene Biomarkers Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Collaborative Study of 1,3 Butadiene Biomarkers clinical trial. Participants frequently get the best healthcare available for their Collaborative Study of 1,3 Butadiene Biomarkers condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "C" Clinical Trials Conditions > Collaborative Study of 1,3 Butadiene Biomarkers  Collaborative Study of 1,3 Butadiene Biomarkers
Collaborative Study of 1,3 Butadiene Biomarkers
For Condition: Cancer
Status: Recruiting
Sponsor(s): National Institute of Environmental Health Sciences (NIEHS) ,
Synopsis: Butadiene is a suspect human carcinogen to which most people are exposed daily. Exposures are difficult to measure by air sampling. This study examines the relationship between air levels and several biomarkers of exposure. Biomarkers are substances analyzed in human tissues or waste products. Adducts are materials formed when a chemical reacts with a biological material. In this study we are looking at biomarkers in the blood: hemoglobin and DNA adducts, and urinary metabolites. If a strong relationship is found then the amounts of biomarkers in a person's blood or urine can tell us how much they have been exposed. The tests are being conducted on petrochemical workers who have a wide range of exposures to butadiene. An international group of investigators is conducting the study.
Details:
Eligibility:
Study Type: Observational, Natural History, Longitudinal, Defined Population, Prospective Study
Minimum Age/Maximum Age: 19 Years/65 Years
Genders: Both
Protocol Entry Criteria: Healthy adults without metabolic disorders
Total Enrollment: 80
Location and Contact Information:
Harvard School of Public Health *Recruiting*
Boston, Massachusetts, 02115
United States
Recruiting Thomas Smith 617-432-3315
National Chung Kung University *Recruiting*
Tainan, ,
Taiwan, Province of China
Recruiting Ho-Yuan Chang
Additional Information:
Study ID Numbers: 9401-CP-001;
Study Start Date: July 1999
Record last reviewed: July 2000
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00023140
Other Cancer Studies:
1. Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
2. Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Allogeneic Transplantation
3. Screening Patients for NCI Protocol Eligibility
4. Biomarkers of Benzene Exposure in Inner City Residents
5. High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors
Related Studies:
Other Cancer Clinical Trials
Other Massachusetts Clinical Trials
Other Boston Clinical Trials
Collaborative Study of 1,3 Butadiene Biomarkers
|
|
|
|
|
|
|
|
